Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 2;15(1):73.
doi: 10.1186/s12937-016-0188-3.

Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study

Affiliations

Prevalence of glutamine deficiency in ICU patients: a cross-sectional analytical study

Arista Nienaber et al. Nutr J. .

Abstract

Background: Not only is glutamine deficiency an independent predictor of mortality in intensive care unit (ICU) patients, but glutamine supplementation is also recommended for its proven outcome benefits. However, recent data suggest that early glutamine supplementation in certain patient groups increase mortality. The aim of this study was to investigate plasma glutamine levels of adult ICU patients in the South African setting and to determine relationships between glutamine levels, gender, diagnostic categories and selected inflammatory markers. The data from this study will be used as baseline measurement to support a large scale study that will be undertaken in the South African ICU population.

Methods: This cross-sectional, analytical study included 60 mixed adult ICU patients within 24 h post ICU admission. Plasma glutamine levels were determined on admission. The relationship between glutamine levels, Interleukin-6 (IL-6) and C-reactive protein (CRP); as well as gender- and diagnosis-related differences in glutamine levels were also investigated. A non-parametric ROC curve was computed to determine the CRP concentration cut-off point above which glutamine becomes deficient.

Results: The median plasma glutamine level (497 μmol/L) was in the normal range; however, 38.3 % (n = 23) of patients had deficient (<420 μmol/L) and 6.7 % (n = 4) had supra-normal glutamine levels (>930 μmol/L). No significant difference could be detected between glutamine levels and gender or diagnosis categories as a group. When only the medical and surgical categories were compared, the median plasma glutamine level of the medical patients were significantly lower than that of the surgical patients (p = 0.042). Glutamine showed inverse associations with CRP levels (r = -0.44, p < 0.05) and IL-6 concentrations (r = -0.23, p = 0.08). A CRP cut-off value of 95.5 mg/L was determined above which glutamine levels became deficient.

Conclusions: About a third of patients (38 %) were glutamine deficient on admission to ICU, whereas some presented with supra-normal levels. While glutamine levels correlated inversely with inflammatory markers, and a CRP value of above 95.5 mg/L indicated potential glutamine deficiency, the clinical application of this finding needs further investigation.

Keywords: C-reactive protein; Gender; Glutamine; Intensive care unit; Interleukin-6.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Relationship between plasma glutamine and interleukin-6 levels (r = −0.23, p = 0.08)
Fig. 2
Fig. 2
Relationship between plasma glutamine and CRP levels (r = −0.44, p < 0.05). CRP, C-reactive protein
Fig. 3
Fig. 3
The receiver operating characteristic curve, computing the C-reactive protein level above which glutamine becomes deficient. Area under curve (AUC): 0.759 (95 % CI 0.653; 0.865, p < 0.0001)
Fig. 4
Fig. 4
Plasma glutamine levels presented per interleukin-6 category. The area between the dashed lines represents normal plasma glutamine reference ranges. GLN, glutamine; IL-6, interleukin-6
Fig. 5
Fig. 5
Plasma glutamine levels presented per C-reactive protein category. The area between the dashed lines represents normal plasma glutamine reference ranges. GLN, glutamine; CRP, C-reactive protein

References

    1. Dupertuis YM, Meguid MM, Pichard C. Advancing from immunonutrition to a pharmaconutrition: a gigantic challenge. Curr Opin Clin Nutr. 2009;12:398–403. doi: 10.1097/MCO.0b013e32832c4ce1. - DOI - PubMed
    1. Bergstrom J, Furst P, Noree L, Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol. 1974;36:693–7. - PubMed
    1. Essen P, Wernerman J, Sonnenfeld T, Thunell S, Vinnars E. Free amino acids in plasma and muscle during 24 hours post‐operatively–a descriptive study. Clin Phys. 1992;12:163–77. doi: 10.1111/j.1475-097X.1992.tb00303.x. - DOI - PubMed
    1. Gamrin L, Andersson K, Hultman E, Nilsson E, Essén P, Wernerman J. Longitudinal changes of biochemical parameters in muscle during critical illness. Metabolism. 1997;46:756–62. doi: 10.1016/S0026-0495(97)90119-0. - DOI - PubMed
    1. Pérez-Bárcena J, García-de-Lorenzo A, Buño A, Llompart-Pou JA. A randomized trial of intravenous glutamine supplementation in trauma ICU patients: response to the comments by Ozcelik et al. Intens care med. 2014;40:1397–7. - PubMed

Publication types